Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $81.9400 (8.76%) ($77.7100 - $81.9400) on Thu. Nov. 10, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.17% (three month average) | RSI | 46 | Latest Price | $81.9400(8.76%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 5.7% a day on average for past five trading days. | Weekly Trend | LGND declines -9.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IWM(44%) IWN(44%) IWO(43%) IWC(41%) SDY(39%) | Factors Impacting LGND price | LGND will decline at least -2.085% in a week (0% probabilities). VXX(-16%) UNG(-10%) UUP(-7%) TBT(-5%) SHY(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.085% (StdDev 4.17%) | Hourly BBV | 1.8 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $50.3(-38.61%) | 5 Day Moving Average | $70.4(16.39%) | 10 Day Moving Average | $74.06(10.64%) | 20 Day Moving Average | $80.98(1.19%) | To recent high | -23.9% | To recent low | 32.6% | Market Cap | $1.317b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |